Stevens–Johnson syndrome associated with daclatasvir and sofosbuvir co-therapy in hepatitis C treatment: a rare case report
Even though SJS is rare, the possibility that it might have occurred due to sofosbuvir-daclatasvir highlights the need for clinicians to be vigilant while prescribing this regime and educate the patients about the signs and symptoms of SJS. Clinical practices can lower hazards and improve patient safety by implementing these measures.
Authors
- Syed Faraz Ul Hassan Shah Gillani (ORCID: https://orcid.org/0000-0001-9128-7163)
- Rahmat Ullah (ORCID: https://orcid.org/0000-0001-6516-9382)
- Soleen Ghafoor (ORCID: https://orcid.org/0000-0002-8459-7363)
- Ihsan Qamar (ORCID: https://orcid.org/0009-0002-6491-1404)
- Zabeeh Ullah
- Iftikhar Alam (ORCID: https://orcid.org/0000-0002-6917-8267)
- Ubaid Ur Rehman (ORCID: https://orcid.org/0009-0009-0910-896X)
- Waseem Sajjad (ORCID: https://orcid.org/0000-0003-1112-4773)
- Areeba Inam
- Hussain Danyal Razzaq
- Taqweem Khwajakhail
- Hassan Razzaq
Institutions
- Ayub Medical College (PK)
- King Edward Medical University (PK)
- Kabul University (AF)
- Punjab Medical College (PK)
- Landmark College (US)
- Mayo Hospital (PK)
Publication Details
- Journal
- Annals of Medicine and Surgery
- Published
- 2025-08-28
- DOI
- https://doi.org/10.1097/ms9.0000000000003743
- Citations
- 1
- Primary Topic
- Hepatitis C virus research
- Type
- article
- Field-Weighted Citation Impact
- 1.32